Skip to main content
Brian Berger, MD, Ophthalmology, Austin, TX, University Medical Center at Brackenridge

BrianBBergerMDboard certified

Ophthalmology Austin, TX

Retinal Disease, Uveitis

president, Retina Research Center

Dr. Berger is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Berger's full profile

Already have an account?

Education & Training

  • Medical College of Wisconsin Affiliated Hospitals
    Medical College of Wisconsin Affiliated HospitalsResidency, Ophthalmology, 1979 - 1980
  • University of Illinois College of Medicine at Chicago
    University of Illinois College of Medicine at ChicagoResidency, Ophthalmology, 1976 - 1979
  • Valleywise Health
    Valleywise HealthInternship, Transitional Year, 1975 - 1976
  • University of Chicago Division of the Biological Sciences The Pritzker School of Medicine
    University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1975

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 1981 - 2026
  • IL State Medical License
    IL State Medical License 1976 - 2014
  • WI State Medical License
    WI State Medical License 1979 - 1981
  • American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

  • Top Doctors:SE Texas Castle Connolly, 2013
  • Fellow (FAAO) American Academy of Ophthalmology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • A CCR2/5 Inhibitor, PF-04634817, Is Inferior to Monthly Ranibizumab in the Treatment of Diabetic Macular Edema  
    Brian Berger, Douglas Girgenti, Ronald A Schachar, Marla B Sultan, Investigative Ophthalmology and Visual Science

Press Mentions

  • Effect of Initial Management with Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients with Diabetic Macular Edema Involving the Center of the Macula and Good Visual Acuity
    Effect of Initial Management with Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients with Diabetic Macular Edema Involving the Center of the Macula and Good Visual AcuityMay 1st, 2019

Professional Memberships

Other Languages

  • Spanish

Hospital Affiliations